Details for Patent: 5,608,075
✉ Email this page to a colleague
Summary for Patent: 5,608,075
Title: | Polymorphs of losartan and the process for the preparation of form II of losartan |
Abstract: | Polymorphic forms of Losartan (Formula I) ##STR1## and a process for the preparation of Form II of Losartan. Losartan is known to be useful in the treatment of hypertension. |
Inventor(s): | Campbell, Jr.; Gordon C. (Wilmington, DE), Dwivedi; Anil M. (Newark, DE), Levorse; Dorothy A. (South Amboy, NJ), McCauley; James A. (Bellemeade, NJ), Raghavan; Krishnaswamy S. (Wilmington, DE) |
Assignee: | Merck & Co., Inc. (Rahway, NJ) E. I. Du Pont de Nemours & Company (Wilmington, DE) The DuPont Merck Pharmaceutical Company (Wilmington, DE) |
Application Number: | 08/371,937 |
Patent Claim Types: see list of patent claims | Process; |
Drugs Protected by US Patent 5,608,075
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,608,075
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 1405895 | ⤷ Try a Trial | |||
Australia | 685898 | ⤷ Try a Trial | |||
Canada | 2179067 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |